These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 14523047)

  • 1. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
    Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
    J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited disorders of NF-kappaB-mediated immunity in man.
    Puel A; Picard C; Ku CL; Smahi A; Casanova JL
    Curr Opin Immunol; 2004 Feb; 16(1):34-41. PubMed ID: 14734108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
    Döffinger R; Smahi A; Bessia C; Geissmann F; Feinberg J; Durandy A; Bodemer C; Kenwrick S; Dupuis-Girod S; Blanche S; Wood P; Rabia SH; Headon DJ; Overbeek PA; Le Deist F; Holland SM; Belani K; Kumararatne DS; Fischer A; Shapiro R; Conley ME; Reimund E; Kalhoff H; Abinun M; Munnich A; Israël A; Courtois G; Casanova JL
    Nat Genet; 2001 Mar; 27(3):277-85. PubMed ID: 11242109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Heike T
    Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited disorders of human Toll-like receptor signaling: immunological implications.
    Ku CL; Yang K; Bustamante J; Puel A; von Bernuth H; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
    Immunol Rev; 2005 Feb; 203():10-20. PubMed ID: 15661018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation.
    Yoshioka T; Nishikomori R; Hara J; Okada K; Hashii Y; Okafuji I; Nodomi S; Kawai T; Izawa K; Ohnishi H; Yasumi T; Nakahata T; Heike T
    J Clin Immunol; 2013 Oct; 33(7):1165-74. PubMed ID: 23864385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.
    Petersheim D; Massaad MJ; Lee S; Scarselli A; Cancrini C; Moriya K; Sasahara Y; Lankester AC; Dorsey M; Di Giovanni D; Bezrodnik L; Ohnishi H; Nishikomori R; Tanita K; Kanegane H; Morio T; Gelfand EW; Jain A; Secord E; Picard C; Casanova JL; Albert MH; Torgerson TR; Geha RS
    J Allergy Clin Immunol; 2018 Mar; 141(3):1060-1073.e3. PubMed ID: 28629746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency.
    McDonald DR; Mooster JL; Reddy M; Bawle E; Secord E; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):900-7. PubMed ID: 17931563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding NEMO: genetic disorders of NF-[kappa]B activation.
    Orange JS; Geha RS
    J Clin Invest; 2003 Oct; 112(7):983-5. PubMed ID: 14523034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO.
    Carrol ED; Gennery AR; Flood TJ; Spickett GP; Abinun M
    Arch Dis Child; 2003 Apr; 88(4):340-1. PubMed ID: 12651765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
    Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F
    J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
    Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
    Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heritable defects of the human TLR signalling pathways.
    Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
    J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.
    Hubeau M; Ngadjeua F; Puel A; Israel L; Feinberg J; Chrabieh M; Belani K; Bodemer C; Fabre I; Plebani A; Boisson-Dupuis S; Picard C; Fischer A; Israel A; Abel L; Veron M; Casanova JL; Agou F; Bustamante J
    Blood; 2011 Jul; 118(4):926-35. PubMed ID: 21622647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes.
    Smahi A; Courtois G; Rabia SH; Döffinger R; Bodemer C; Munnich A; Casanova JL; Israël A
    Hum Mol Genet; 2002 Oct; 11(20):2371-5. PubMed ID: 12351572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy.
    Schimke LF; Rieber N; Rylaarsdam S; Cabral-Marques O; Hubbard N; Puel A; Kallmann L; Sombke SA; Notheis G; Schwarz HP; Kammer B; Hökfelt T; Repp R; Picard C; Casanova JL; Belohradsky BH; Albert MH; Ochs HD; Renner ED; Torgerson TR
    J Clin Immunol; 2013 Aug; 33(6):1088-99. PubMed ID: 23708964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
    Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency.
    Dupuis-Girod S; Cancrini C; Le Deist F; Palma P; Bodemer C; Puel A; Livadiotti S; Picard C; Bossuyt X; Rossi P; Fischer A; Casanova JL
    Pediatrics; 2006 Jul; 118(1):e205-11. PubMed ID: 16769798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.